Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $79.66 in the prior trading day, CVS Health Corp (NYSE: CVS) closed at $80.67, up 1.27%. In other words, the price has increased by $1.27 from its previous closing price. On the day, 8.04 million shares were traded. CVS stock price reached its highest trading level at $81.93 during the session, while it also had its lowest trading level at $79.85.
Ratios:
Our goal is to gain a better understanding of CVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.80. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $91.
On August 18, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $79.
Robert W. Baird Upgraded its Neutral to Outperform on August 14, 2025, while the target price for the stock was maintained at $82.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 23 ’24 when CAPOZZI HEIDI B bought 35 shares for $56.85 per share. The transaction valued at 1,990 led to the insider holds 85 shares of the business.
Finucane Anne A. sold 7,500 shares of CVS for $532,650 on Aug 20 ’25. The Director now owns 22,156 shares after completing the transaction at $71.02 per share. On Aug 20 ’25, another insider, Finucane Anne A., who serves as the Director of the company, bought 7,500 shares for $70.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 102315884544 and an Enterprise Value of 171038883840. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.51, and their Forward P/E ratio for the next fiscal year is 11.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 0.445 whereas that against EBITDA is 12.241.
Stock Price History:
The Beta on a monthly basis for CVS is 0.59, which has changed by 0.26700175 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $79.94, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is 10.35%, while the 200-Day Moving Average is calculated to be 23.81%.
Shares Statistics:
The stock has traded on average 7.71M shares per day over the past 3-months and 7458510 shares per day over the last 10 days, according to various share statistics. A total of 1.27B shares are outstanding, with a floating share count of 1.27B. Insiders hold about 0.15% of the company’s shares, while institutions hold 87.55% stake in the company. Shares short for CVS as of 1759190400 were 18936807 with a Short Ratio of 2.46, compared to 1756425600 on 18801166. Therefore, it implies a Short% of Shares Outstanding of 18936807 and a Short% of Float of 1.50999995.
Dividends & Splits
In the trailing 12 months, CVS’s forward annual dividend rate was 2.66, compared to 2.66 this year. Against a Trailing Annual Dividend Yield of 0.033391915. The stock’s 5-year Average Dividend Yield is 3.16. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-07-22 with an ex-dividend date of 2025-10-23. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of CVS Health Corp (CVS) is currently being evaluated by 24.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.95, with high estimates of $1.05 and low estimates of $0.88.
Analysts are recommending an EPS of between $6.5 and $6.22 for the fiscal current year, implying an average EPS of $6.37. EPS for the following year is $7.16, with 29.0 analysts recommending between $7.7 and $6.55.
Revenue Estimates
20 analysts predict $98.83B in revenue for. The current quarter. It ranges from a high estimate of $102.99B to a low estimate of $97.24B. As of. The current estimate, CVS Health Corp’s year-ago sales were $95.43BFor the next quarter, 20 analysts are estimating revenue of $101.32B. There is a high estimate of $106.12B for the next quarter, whereas the lowest estimate is $99.58B.
A total of 24 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $402.62B, while the lowest revenue estimate was $390.58B, resulting in an average revenue estimate of $393.56B. In the same quarter a year ago, actual revenue was $372.81BBased on 25 analysts’ estimates, the company’s revenue will be $410.62B in the next fiscal year. The high estimate is $430.06B and the low estimate is $391.95B.
